267 related articles for article (PubMed ID: 32584876)
1. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
2. Anaphylaxis Due to the Excipient Polysorbate 80.
Palacios Castaño MI; Venturini Díaz M; Lobera Labairu T; González Mahave I; Del Pozo Gil MD; Blasco Sarramián A
J Investig Allergol Clin Immunol; 2016; 26(6):394-396. PubMed ID: 27996954
[No Abstract] [Full Text] [Related]
3. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
[TBL] [Abstract][Full Text] [Related]
4. Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants?
Singh SK; Mahler HC; Hartman C; Stark CA
J Pharm Sci; 2018 Nov; 107(11):2735-2741. PubMed ID: 30055223
[TBL] [Abstract][Full Text] [Related]
5. Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.
Perino E; Freymond N; Devouassoux G; Nicolas JF; Berard F
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):664-666. PubMed ID: 29481891
[No Abstract] [Full Text] [Related]
6. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
Dantal J
Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis to intravenous paracetamol containing povidone. A case report and narrative review of excipient allergy related to anaesthesia.
Preuss JF; Goddard CE; Clarke RC; Platt PR; Sadleir PH
Anaesth Intensive Care; 2020 Sep; 48(5):404-408. PubMed ID: 33016081
[TBL] [Abstract][Full Text] [Related]
9. Analyzing excipient-related adverse events in antiseizure drug formulations.
Ionova Y; Peterson T; Wilson L
Epilepsy Res; 2022 Aug; 184():106947. PubMed ID: 35661571
[TBL] [Abstract][Full Text] [Related]
10. Excipient-drug interactions in parenteral formulations.
Akers MJ
J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
Drug Dev Ind Pharm; 2016 Apr; 42(4):676-684. PubMed ID: 26266963
[TBL] [Abstract][Full Text] [Related]
12. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
[No Abstract] [Full Text] [Related]
13. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin.
Steele RH; Limaye S; Cleland B; Chow J; Suranyi MG
Nephrology (Carlton); 2005 Jun; 10(3):317-20. PubMed ID: 15958049
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
Itkin YM; Trujillo TC
Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
Abrantes CG; Duarte D; Reis CP
J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
Saito J; Nakamura H; Akabane M; Yamatani A
Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
[TBL] [Abstract][Full Text] [Related]
17. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
Ursino MG; Poluzzi E; Caramella C; De Ponti F
Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
[TBL] [Abstract][Full Text] [Related]
18. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.
Caballero ML; Krantz MS; Quirce S; Phillips EJ; Stone CA
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2968-2982. PubMed ID: 33737254
[TBL] [Abstract][Full Text] [Related]
19. Excipients in Anesthesia Medications.
Burbridge MA; Jaffe RA
Anesth Analg; 2019 May; 128(5):891-900. PubMed ID: 29505449
[TBL] [Abstract][Full Text] [Related]
20. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
